Статья

SARS-CoV-2 Epitopes Are Recognized by a Public and Diverse Repertoire of Human T Cell Receptors

A. Shomuradova, M. Vagida, S. Sheetikov, K. Zornikova, D. Kiryukhin, A. Titov, I. Peshkova, A. Khmelevskaya, D. Dianov, M. Malasheva, A. Shmelev, Y. Serdyuk, D. Bagaev, A. Pivnyuk, D. Shcherbinin, A. Maleeva, N. Shakirova, A. Pilunov, D. Malko, E. Khamaganova, B. Biderman, A. Ivanov, M. Shugay, G. Efimov,
2021

Understanding the hallmarks of the immune response to SARS-CoV-2 is critical for fighting the COVID-19 pandemic. We assessed antibody and T cell reactivity in convalescent COVID-19 patients and healthy donors sampled both prior to and during the pandemic. Healthy donors examined during the pandemic exhibited increased numbers of SARS-CoV-2-specific T cells, but no humoral response. Their probable exposure to the virus resulted in either asymptomatic infection without antibody secretion or activation of preexisting immunity. In convalescent patients, we observed a public and diverse T cell response to SARS-CoV-2 epitopes, revealing T cell receptor (TCR) motifs with germline-encoded features. Bulk CD4+ and CD8+ T cell responses to the spike protein were mediated by groups of homologous TCRs, some of them shared across multiple donors. Overall, our results demonstrate that the T cell response to SARS-CoV-2, including the identified set of TCRs, can serve as a useful biomarker for surveying antiviral immunity. © 2020 Elsevier Inc.Shomuradova et al. assessed the immune response to SARS-CoV-2 in convalescent patients and healthy donors. Antigen-specific T cells were increased in convalescents and in donors sampled during the pandemic. The work identified two public epitopes from S-glycoprotein. T cell receptor repertoire profiling of S-glycoprotein-specific lymphocytes revealed public CDR3 motifs. © 2020 Elsevier Inc.

Цитирование

Похожие публикации

Документы

Источник

Версии

  • 1. Version of Record от 2021-04-27

Метаданные

Об авторах
  • A. Shomuradova
    National Research Center for Hematology, Moscow, Russian Federation
  • M. Vagida
    Faculty of Biology, Lomonosov Moscow State University, Moscow, Russian Federation
  • S. Sheetikov
    Eindhoven University of Technology, Eindhoven, Netherlands
  • K. Zornikova
    Center of Life Sciences, Skolkovo Institute of Science and Technology, Moscow, Russian Federation
  • D. Kiryukhin
    Pirogov Russian Medical State University, Moscow, Russian Federation
  • A. Titov
    Shemyakin and Ovchinnikov Institute of Bioorganic Chemistry, Moscow, Russian Federation
  • I. Peshkova
    Center for Precision Genome Editing and Genetic Technologies for Biomedicine, Engelhardt Institute of Molecular Biology, Russian Academy of Sciences, Moscow, Russian Federation
  • A. Khmelevskaya
  • D. Dianov
  • M. Malasheva
  • A. Shmelev
  • Y. Serdyuk
  • D. Bagaev
  • A. Pivnyuk
  • D. Shcherbinin
  • A. Maleeva
  • N. Shakirova
  • A. Pilunov
  • D. Malko
  • E. Khamaganova
  • B. Biderman
  • A. Ivanov
  • M. Shugay
  • G. Efimov
Название журнала
  • Immunity
Том
  • 53
Выпуск
  • 6
Страницы
  • 1245-1257.e5
Ключевые слова
  • coronavirus spike glycoprotein; epitope; lymphocyte antigen receptor; virus antibody; adolescent; adult; asymptomatic infection; CD4+ T lymphocyte; CD8+ T lymphocyte; cell culture; convalescence; female; human; immunity; immunological memory; immunology; lymphocyte activation; male; metabolism; middle aged; pandemic; physiology; young adult; Adolescent; Adult; Antibodies, Viral; Asymptomatic Infections; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Cells, Cultured; Convalescence; COVID-19; Epitopes, T-Lymphocyte; Female; Humans; Immunity; Immunologic Memory; Lymphocyte Activation; Male; Middle Aged; Pandemics; Receptors, Antigen, T-Cell; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Young Adult
Издатель
  • Cell Press
Тип документа
  • journal article
Тип лицензии Creative Commons
  • CC BY-NC-ND
Правовой статус документа
  • Свободная лицензия
Источник
  • scopus